These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25646657)

  • 41. MMR Vaccine-Associated Disseminated Measles in an Immunocompromised Adolescent.
    Stokke JL; Szymanski LJ; Bankamp B; Pratt F; Martines R; Dien-Bard J; Mohandas S
    N Engl J Med; 2021 Sep; 385(13):1246-1248. PubMed ID: 34551236
    [No Abstract]   [Full Text] [Related]  

  • 42. Outbreak of measles and rubella in refugee transit camps.
    Kouadio IK; Koffi AK; Attoh-Toure H; Kamigaki T; Oshitani H
    Epidemiol Infect; 2009 Nov; 137(11):1593-601. PubMed ID: 19379539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NEW PERSPECTIVES IN THE DIAGNOSIS AND THE TREATMENT OF CHILDHOOD FEBRILE EXANTHEMAS.
    Luca MC; Vâţă A; St Luca A; Dorobăţ CM; Brănişteanu DE
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):319-24. PubMed ID: 26204631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.
    Klein NP; Fireman B; Yih WK; Lewis E; Kulldorff M; Ray P; Baxter R; Hambidge S; Nordin J; Naleway A; Belongia EA; Lieu T; Baggs J; Weintraub E;
    Pediatrics; 2010 Jul; 126(1):e1-8. PubMed ID: 20587679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccine-associated measles in a patient treated with natalizumab: a case report.
    Miauton A; Tan R; Pantazou V; Du Pasquier R; Genton B
    BMC Infect Dis; 2020 Oct; 20(1):753. PubMed ID: 33054715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of measles, mumps and rubella viruses by immuno-colorimetric assay and its application in focus reduction neutralization tests.
    Vaidya SR; Kumbhar NS; Bhide VS
    Microbiol Immunol; 2014 Dec; 58(12):666-74. PubMed ID: 25244651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Has the measles-mumps-rubella vaccine been fully exonerated?
    Katz SL
    Pediatrics; 2006 Oct; 118(4):1744-5. PubMed ID: 17015569
    [No Abstract]   [Full Text] [Related]  

  • 50. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(28):603-6. PubMed ID: 8676852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome).
    Azzari C; Gambineri E; Resti M; Moriondo M; Betti L; Saldias LR; G Gelli AM; Vierucci A
    Vaccine; 2005 Feb; 23(14):1668-71. PubMed ID: 15705470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying Vaccine-associated Rash Illness Amidst a Large Measles Outbreak: Minnesota, 2017.
    Martin KG; Banerjee E; McMahon M; Kenyon C; Strain A; Halstead Muscoplat M; Gastañaduy PA; Rota PA; Mody RK; Ehresmann K
    Clin Infect Dis; 2020 Dec; 71(9):e517-e519. PubMed ID: 32067029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Re: "Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design".
    Farrington CP
    Am J Epidemiol; 2004 Apr; 159(7):717-8; author reply 718-20. PubMed ID: 15033652
    [No Abstract]   [Full Text] [Related]  

  • 55. Pancreatic pseudocyst after measles, mumps, and rubella vaccination.
    Verma A; Rastogi R; Srivastava A
    Turk J Gastroenterol; 2017 Mar; 28(2):144-146. PubMed ID: 28082255
    [No Abstract]   [Full Text] [Related]  

  • 56. Local public health response to vaccine-associated measles: case report.
    Hau M; Schwartz KL; Frenette C; Mogck I; Gubbay JB; Severini A; Hiebert J; Deeks SL; Morris SK
    BMC Public Health; 2013 Mar; 13():269. PubMed ID: 23531102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measles: an important cause of fever and rash in a returned traveller.
    Huang GK; Bond KA; Hewitt NH; Johnson PD
    Med J Aust; 2014 Nov; 201(10):605-6. PubMed ID: 25390269
    [No Abstract]   [Full Text] [Related]  

  • 58. Improving vaccine safety through a better understanding of vaccine adverse events.
    Pasternak B; Feenstra B; Melbye M; Hviid A
    Clin Infect Dis; 2015 May; 60(10):1586-7. PubMed ID: 25648238
    [No Abstract]   [Full Text] [Related]  

  • 59. [Sudden bilateral deafness after measles, mumps and rubella vaccination].
    García Callejo FJ; Costa Alcácer I; de Paula Vernetta C; Marco Algarra J
    An Pediatr (Barc); 2005 May; 62(5):482-3. PubMed ID: 15871835
    [No Abstract]   [Full Text] [Related]  

  • 60. [Unilateral VI cranial nerve palsy after vaccination: presentation of a case].
    Ríos L; Martín I; Mercadal M
    An Pediatr (Barc); 2014 Dec; 81(6):e44-5. PubMed ID: 24631101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.